Secondary amyloidosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{Sahar}} | {{CMG}}; {{AE}} {{Sahar}} | ||
{{SK}} | {{SK}}: Reactive amyloidosis | ||
==[[Secondary amyloidosis overview|Overview]]== | ==[[Secondary amyloidosis overview|Overview]]== |
Revision as of 03:50, 3 November 2019
Secondary amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Secondary amyloidosis On the Web |
American Roentgen Ray Society Images of Secondary amyloidosis |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Synonyms and keywords:: Reactive amyloidosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Secondary amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies